Author

Omar Kayali

Institute of Oncology ResearchORCID 0000-0002-6642-2463Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Alberto J. ArribasiD· 1 shared Anastasios StathisiD· 1 shared Chiara TarantelliiD· 1 shared Eleonora CannasiD· 1 shared Elisa CivanelliiD· 1 shared Filippo SprianoiD· 1 shared Francesco BertoniiD· 1 shared Giorgia Risi· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alberto J. ArribasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 23, 2025

The anti-metabolite KAT/3BP has in vitro and in vivo anti-tumor activity in lymphoma models

Chiara Tarantelli, Filippo Spriano, Elisa Civanelli…·Francesco Bertoni

This study evaluates KAT/3BP, a 3BP derivative, showing in vitro and in vivo anti-tumor activity against lymphoma models, including resistant cell lines and synergistic effects with existing therapies.

DOI 10.1101/2025.04.23.650181

mouseexperimental assay

𝕏 PostBluesky